Financial Performance of Medicare Advantage, Individual, and Group Health Insurance Markets

Medicare-for-All proposals have sparked discussion about the role of private health insurance in the U.S. health care system. Some of the current Medicare-for-All proposals would essentially eliminate private insurance.

Read More

As ‘Medicare for All’ Debate Gains Steam, Many Americans Are On The Fence: Survey

Though support or opposition for “Medicare for All” is dominating the 2020 primary headlines, a large group of Americans is more ambivalent about the proposal, a new survey shows. 

Read More

Medicare to Cover Expensive Cancer Cell Therapies

The U.S. Centers for Medicare and Medicaid Services (CMS) on Wednesday said it has finalized a decision to cover expensive cancer cell therapies sold by Gilead Sciences Inc and Novartis AG.

Read More

California AG Takes On ‘Pay for Delay’ Generic Drug Deals

California’s attorney general touted a legal victory last week against drugmakers who he said made secretive, backroom deals to keep less expensive drugs off the market.

Read More

San Jose Sues CVS, Walgreens and Other Drug Distributors, Manufacturers Over Opioids

San Jose has joined cities across the country in calling out the makers and sellers of prescription painkillers like OxyContin and Percocet for furthering the nation’s opioid epidemic.

Read More

CMS Tees Up Medicare Plan Finder Update

The Centers for Medicare & Medicaid Services (CMS) is planning to launch updates to its Medicare Plan Finder (MPF) this month after a report from a government watchdog flagged significant usability concerns with the tool. 

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square